| Schizophrenia risk from complex variation of complement component 4 A Sekar, AR Bialas, H De Rivera, A Davis, TR Hammond, N Kamitaki, ... Nature 530 (7589), 177-183, 2016 | 2220 | 2016 |
| Molecular diversity and specializations among the cells of the adult mouse brain A Saunders, EZ Macosko, A Wysoker, M Goldman, FM Krienen, ... Cell 174 (4), 1015-1030. e16, 2018 | 1247 | 2018 |
| Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP J Xu, P Kurup, Y Zhang, SM Goebel-Goody, PH Wu, AH Hawasli, ... Journal of Neuroscience 29 (29), 9330-9343, 2009 | 331 | 2009 |
| Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders SM Goebel-Goody, M Baum, CD Paspalas, SM Fernandez, NC Carty, ... Pharmacological reviews 64 (1), 65-87, 2012 | 167 | 2012 |
| The monoamine oxidase A (MAOA) genetic predisposition to impulsive violence: Is it relevant to criminal trials? ML Baum Neuroethics 6 (2), 287-306, 2013 | 82 | 2013 |
| A STEP forward in neural function and degeneration ML Baum, P Kurup, J Xu, PJ Lombroso Communicative & integrative biology 3 (5), 419-422, 2010 | 23 | 2010 |
| The neuroethics of biomarkers: What the development of bioprediction means for moral responsibility, justice, and the nature of mental disorder ML Baum Oxford University Press, 2016 | 22 | 2016 |
| CUB and Sushi Multiple Domains 1 (CSMD1) opposes the complement cascade in neural tissues ML Baum, DK Wilton, A Muthukumar, RG Fox, A Carey, W Crotty, ... bioRxiv, 2020.09. 11.291427, 2020 | 21 | 2020 |
| Duties toward Patients with Psychiatric Illness RC Conrad, ML Baum, SB Shah, NC Levy‐Carrick, J Biswas, ... Hastings Center Report 50 (3), 67-69, 2020 | 18 | 2020 |
| Behavioral biomarkers: What are they good for M Baum, J Savulescu Bioprediction, biomarkers, and bad behavior: Scientific, legal, and ethical …, 2013 | 15 | 2013 |
| Nudge ethics: just a game of billiards? CJ Huang, ML Baum The American Journal of Bioethics 12 (2), 22-24, 2012 | 12 | 2012 |
| Patient requests for off-label bioprediction of dementia ML Baum Cambridge Quarterly of Healthcare Ethics 25 (4), 686-690, 2016 | 7 | 2016 |
| How collaboration between bioethicists and neuroscientists can advance research I Hyun, JC Scharf-Deering, S Sullivan, JD Aach, P Arlotta, ML Baum, ... Nature Neuroscience 25 (11), 1399-1401, 2022 | 6 | 2022 |
| Definition and Scope of Epidemiology J Van den Broeck, JR Brestoff, M Baum Epidemiology: Principles and Practical Guidelines, 3-18, 2013 | 3 | 2013 |
| Author Correction: Schizophrenia risk from complex variation of complement component 4 A Sekar, AR Bialas, H de Rivera, A Davis, TR Hammond, N Kamitaki, ... Nature 601 (7892), E4-E5, 2022 | 2 | 2022 |
| Incidental Findings from Deep Phenotyping Research in Psychiatry: Legal and Ethical Considerations A Kim, M Hsu, A Koire, ML Baum Cambridge Quarterly of Healthcare Ethics 31 (4), 482-486, 2022 | 1 | 2022 |
| A rational basis for chemoprevention of prostate cancer CJ Huang, ML Baum The American Journal of Bioethics 11 (12), 27-29, 2011 | 1 | 2011 |
| Is Diminished Free Will Legally Relevant and Is Enhanced Free Will Possible? ML Baum, CJ Huang AJOB Neuroscience 2 (3), 59-61, 2011 | 1 | 2011 |
| Returning Individual Research Results from Digital Phenotyping in Psychiatry FX Shen, ML Baum, N Martinez-Martin, AS Miner, M Abraham, ... The American Journal of Bioethics, 1-22, 2023 | | 2023 |
| Is it psychosis, or an autoimmune encephalitis? ML Baum, MC Johnson, P Lizano Current Psychiatry 21 (8), 31, 2022 | | 2022 |
